A Senior Advisor, as well as Co-Founder and Partner Emeritus on several successful joint initiatives with The Triana Group since its inception, Jerry Sanders is the CEO of San Francisco Science.
Jerry Sanders started his career in international finance and corporate law at Simpson Thacher and Bartlett, a New York City law firm, where he represented foreign governments in international transactions and prominent families of substantial wealth both in the US and abroad. After several years in Europe and the Middle East, he settled in San Francisco to lead The Shaw Group, an incubator of medical device companies. He was an advisor to the founding group of AVE (now Ave-Medtronics) and later, he started his own medical device companies. He served as founder and CEO of BaFF (sold to Boston Scientific), founder and CEO of ArteriA (sold to Gore), founder and CEO of X-Cardia (sold to Imagyn), founder and CEO of S3 (sold to Tyco).
Jerry Sanders also teaches at Oxford University’s Said Business School. He is the main subject of a Harvard Business School case study entitled “The Jerry Sanders Case”, which describes how, with an investment of $180,000 he successfully “sold his medical device company for more than $33 million in less than 10 months”.
A graduate of Queen’s College, Jerry is a Juris Doctor from The University of Texas Law School at Austin, and former Post-Graduate Certificant at the Goethe Institute in Germany.